Developed by Novo Nordisk, this long-acting amylin analogue works by activating amylin receptors throughout the body, particularly in areas that regulate appetite and digestive function [1]
When to seek immediate medical attention Regardless of which tirzepatide formulation you have used or are currently using, seek immediate medical care if you experience: Severe abdominal pain that does not resolve (potential pancreatitis) Signs of allergic reaction including swelling, difficulty breathing, or widespread rash Persistent vomiting lasting more than 24 hours Signs of dehydration including dark urine, dizziness, and rapid heartbeat Vision changes (potential thyroid concerns) Severe joint pain or muscle pain that interferes with daily function These symptoms warrant professional evaluation whether you are on injectable, oral, or any other formulation of tirzepatide or GLP-1 medications
In the SURPASS-1 trial, investigators reported an approximate 26% reduction in total fat mass compared with placebo
Y.XuD.YinJ
Summary updated in July 2014 by Peter Renner and Markus Horneber
Science over social media